Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Akathisia Induced by Abrupt Withdrawal of Risperidone: A Case Report
2
x
$
30.00
John S. Markowitz, PharmD: The Emerging Recognition of Herb-Drug Interactions With a Focus on St. John’s Wort (Hypericum Perforatum)
1
x
$
30.00
The Effectiveness of Long-Acting Injectable Risperidone in a Population of Psychiatric Out-Patients: 1-Year Naturalistic Study
1
x
$
30.00
Madhukar H. Trivedi - Research Evaluating the Value of Augmenting Medication with Psychotherapy:Rationale and Design
1
x
$
30.00
Effectiveness of a Brain-Computer Interface Based Programme for the Treatment of ADHD: A Pilot Study
1
x
$
30.00
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
1
x
$
30.00
An Approach to the Pharmacotherapy of Neuroleptic Malignant Syndrome
1
x
$
30.00
Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais
1
x
$
30.00
Psychopharmacology Bulletin VOL 48 No. 3, 2018 - Full Issue Stacked PDF
1
x
$
90.00
Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine
1
x
$
30.00
OPEN ACCESS: Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future
1
x
$
0.00
Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
1
x
$
30.00
M. Ojinga Harrison, MD: Antipsychotic Medications and Sudden Cardiac Death
1
x
$
30.00
Autism Spectrum Disorder Screening at 18–36 Months in Infants with Moderate and Severe Neonatal Encephalopathy: Is Routine Screening Required? (OPEN ACCESS)
1
x
$
0.00
Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity
1
x
$
30.00
Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders
1
x
$
30.00
Induction of Psychosis by Cyclobenzaprine
1
x
$
30.00
Christian G. Schmahl, MD: Neurobiological Correlates of Borderline Personality Disorder
1
x
$
30.00
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
1
x
$
30.00
Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric Pharmacist
1
x
$
30.00
Treatment of Pathological Gambling with Naltrexone Pharmacotherapy and Brief Intervention: A Pilot Study
1
x
$
30.00
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
1
x
$
30.00
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis
1
x
$
30.00
View Cart
Checkout
Home
acute alcoholic hallucinosis
“Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Relationship of the 1846G > A Polymorphism of the CYP2D6 Gene to the Equilibrium Concentration Levels of Haloperidol in Patients with Acute Alcoholic Hallucinosis
$
30.00
Add to cart
Details
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis
$
30.00
Add to cart
Details
Page load link
Go to Top
